$ARAY 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases-while making commonly treatable cases even easier-to meet the full spectrum of patient needs. Accuray is dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as they partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide.

CEO

Joshua Levine

Exchange

NASDAQ

Website

www.accuray.com

$430M

Total Revenue

932

Employees

$182M

Market Capitalization

-15.97

Price/Earning ratio

Company News

19,383 Shares in Accuray Incorporated (NASDAQ:ARAY) Acquired by Diversified Trust Co

5d ago, source: Defense World

Diversified Trust Co acquired a new position in Accuray Incorporated (NASDAQ:ARAY – Get Rating) in the 1st quarter, according ...

Foundry Partners LLC Decreases Stock Holdings in Accuray Incorporated (NASDAQ:ARAY)

5d ago, source: Defense World

Foundry Partners LLC reduced its position in shares of Accuray Incorporated (NASDAQ:ARAY – Get Rating) by 2.0% in the 1st ...

Here's Why You Should Hold on to Accuray (ARAY) Stock For Now

16d ago, source: Yahoo Finance

Accuray Incorporated ARAY is well poised for growth in the coming quarters, backed by its solid global reach. A solid third-quarter fiscal 2022 performance, along with strong demand for its ...

Accuray gains as B. Riley starts coverage with Buy noting YTD selloff

7d ago, source: Seeking Alpha

Accuray (ARAY), a developer of radiation therapy systems is trading higher for the fourth consecutive session on Thursday ...

Diversified Trust Co Acquires New Shares in Accuray Incorporated (NASDAQ:ARAY)

5d ago, source: ETF Daily News

Accuray Incorporated has a 52 week low of $1.70 and a 52 week high of $5.93. Accuray ( NASDAQ:ARAY – Get Rating ) last posted its quarterly earnings data on Wednesday, April 27th.

Accuray Inc - Stock Quote ARAY

3d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Foundry Partners LLC Reduces Position in Accuray Incorporated (NASDAQ:ARAY)

5d ago, source: ETF Daily News

Accuray Incorporated has a one year low of $1.70 and a one year high of $5.93. Accuray ( NASDAQ:ARAY – Get Rating ) last released its earnings results on Wednesday, April 27th.

Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions

29d ago, source: Yahoo Finance

and SASKATCHEWAN, Canada, June 2, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Limbus AI Inc. announced today they are partnering to augment Accuray adaptive radiotherapy ...

ZAP Surgical Announces Chairman of Foxconn Technology Joins Board of Directors

18h ago, source: Associated Press

ZAP Surgical Systems, Inc., developer and manufacturer of the ZAP-X® surgical robot for non-invasive ablation of brain tumors, today announced that the Chairman of Foxconn Technology Co Ltd, Lu Jun-Fu ...

Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions

29d ago, source: Morningstar%2c Inc.

Advisor Insights Personal Finance Market Volatility Retirement Planning Start Investing Save for College Best Investments See All ...

Here's Why You Should Hold on to Accuray (ARAY) Stock For Now

16d ago, source: Yahoo Finance

Accuray Incorporated ARAY is well poised for growth in the coming quarters, backed by its solid global reach. A solid third-quarter fiscal 2022 performance, along with strong demand for its products, ...

My Portfolio